MicroRNA-302a functions as a putative tumor suppressor in colon cancer by targeting Akt

Shengjie Sun1, Guoqing Zhang1, Zhiyong Wu1

  • 1Department of Oncology, General Hospital of People's Liberation Army, Beijing, 100853, China.

Plos One
|December 27, 2014
PubMed

Insights

MicroRNAs (miRNAs), specifically miRNA-302a, are downregulated in colon cancer. Restoring miRNA-302a suppresses tumor growth and proliferation, indicating its potential as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Context:

  • Micro RNAs (miRNAs) are key regulators in biological processes, including cancer development.
  • The miRNA-302 family is implicated in carcinogenesis.
  • Colon cancer remains a significant global health challenge.

Purpose:

  • To investigate the role and mechanism of miRNA-302a in colon cancer.
  • To analyze miRNA-302a expression levels in colon cancer tissues.
  • To evaluate the functional impact of miRNA-302a on colon cancer cell behavior.

Summary:

  • MiRNA-302a expression is significantly downregulated in colon cancer tissues compared to normal tissues.
  • Overexpression of miRNA-302a inhibits colon cancer cell proliferation and induces G1/S cell cycle arrest in vitro and in vivo.
  • MiRNA-302a directly targets AKT, modulating the AKT-GSK3β-cyclin D1 pathway.

Impact:

  • MiRNA-302a functions as a tumor suppressor in colon cancer.
  • These findings highlight miRNA-302a as a potential therapeutic target for colon cancer treatment.
  • Understanding miRNA-302a's role provides insights into colon cancer pathogenesis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
25.1K
MicroRNAs01:22

MicroRNAs

12.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K